A research team has discovered a mechanism in which blood stem cells respond to acute, severe anemia, through lipoprotein metabolism modification. It has been known how immediate erythroid precursors ...

The researchers demonstrated that NUDCD3 mutations impede a crucial gene-rearranging mechanism known as V(D)J recombination ...

Red blood cells are the most abundant cells in the body. It has long been known that when red blood cells break down or anemia occurs due to bleeding, the hormone erythropoietin (EPO) increases, ...

An outstanding Newcastle University researcher is among the first eight awarded a Royal Society Career Development Fellowship ...

Red blood cells are the most abundant cells in the body. It has long been known that when red blood cells break down or ...

RxCell has received a US patent for an iPSC-based cell therapy approach, a method of generating multiple cellular therapy ...

GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells faster and simpler than current methods.

GC Therapeutics (GCTx) has launched with its TFome platform, developed by scientists at Harvard and the Wyss Institute, ...

InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia: Beijing Friday, September 20, 2024, 18:00 Hrs [IST] InnoCare Pharma ...

Shareholders approve name change and rebranding to Centenara Labs AG (“Centenara”) Rebrand positions business for strategic initiatives designed to support development of therapies for regenerative ...

A Vietnamese university lecturer based in London has become the first Vietnamese scientist to receive the prestigious ...

RxCell Inc. is pleased to announce the issuance of U.S. Patent 11,946,069 entitled "Method for Generating Multiple Cellular Products from Single Pluripotent Cell Source", a significant advancement in ...